Category: Finance
ASX Health Stocks: Botanix to get FDA approval by June; 4DMedical partners with global player, Philips
Botanix expected to get FDA NDA approval in June 2024 4DMedical signs deal with global player, Philips Cannabis stock Vitura Health signs deal with WholeLife [more…]
54g/t gold? Brightstar Resources’ drilling bonanza at Menzies returns the goods
Shallow gold results including 1m at 54.77g/t gold have been received in a 42-hole +2,800m drilling campaign Brightstar says the results illustrate the potential for [more…]
Dateline’s 133m sulphide intersection extends high-grade sedimentary breccia zone at Colosseum
Diamond hole intersects 133m of sulphide at Dateline’s Colosseum gold mine Result extends sedimentary breccia beyond 76.2m at 8.62g/t gold intercept in hole CM23-08 Intersection [more…]
Top 10 at 10: Uranium speccies on the rise as wilting lithium developer Liontown sinks below $1
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
First Lithium’s drilling paints a pretty picture of Blakala’s lithium prospectivity
Diamond drilling continues to intersect high-grade lithium at Blakala High-grade mineralised strike now confirmed to a length of 960m Drilling is continuing with further assays [more…]
Market Highlights: S&P 500 climbs to record high, Big 4 banks’ earnings prediction, and 5 ASX small caps to watch
ASX to climb after S&P 500 hit record high Tesla and IBM are set to release their earnings this week And what Aussie big four [more…]
Confessions of a Day Trader: $2200 in a day? That’s gold, that is!
Each week, Stockhead’s resident day trader gives us a peek at the highs and lows of his trading diary and hints at what might be [more…]
Traders’ Diary: Everything you need to know before the ASX opens
What grabbed the headlines last week? Offshore, resilient economic data in the US was a key theme. Strong retail trade and low initial jobless [more…]
Hot Money Monday: Laramide, Andromeda, Cryosite are rising on momentum. Are they a buy?
The rationale behind momentum trading strategy is that, if there is enough buying force behind the rise in the price of a stock, the stock [more…]
TEN BAGGER: Why fundies are looking off the ASX for the next big thing
Welcome to Ten Bagger, where Lowell Resources Fund chief investment officer John Forwood gives us his take on a sector of the ASX resources market [more…]
